SEGOTX

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in suppressing tumours; pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely for treating cancer; biological preparations for the treatment of cancer; small molecule pharmaceutical preparations for the treatment of cancer; small molecule pharmaceutical preparations for use in suppressing tumours; radiolabeled pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in suppressing tumours.

Licensing of intellectual property

Pharmaceutical research and development; pharmaceutical research and development services in the field of small molecule cancer therapeutics; scientific and technological services, namely, research and development in the field of cancer-related pharmaceuticals and cancer-related drug discovery; research and development of pharmaceutical preparations for treating cancer; providing online non-downloadable software platforms for screening, analyzing, and identifying potential drug candidates; providing online non-downloadable software platforms for screening, analyzing, and identifying potential drug candidates for treating cancer; pharmaceutical research services; testing, inspection, research, or development of pharmaceutical preparations for cancer; providing medical and scientific research information in the field of pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer; laboratory research services relating to pharmaceuticals; laboratory research services relating to pharmaceuticals for treating cancer; consulting services in the field of pharmaceutical research and development; design and development of computer software for use in cancer-related pharmaceutical research, bioinformatics, and cancer-related drug discovery; drug discovery services; research services relating to radiolabeled small molecules for use in oncology; providing a drug discovery screening platform for identifying and characterizing small molecule candidates for the treatment of cancer.

Medical diagnostic services; providing medical information in the field of pharmaceutical research and clinical trials; consulting services in the field of medical testing, diagnostics, and patient-specific therapies; providing medical information in the field of oncology, namely on radiolabeled small molecule diagnostics; consulting services in the field of medical testing and diagnostic screening for cancer.